Palonosetron and hydroxyzine pre-treatment reduces the objective signs of experimentally-induced acute opioid withdrawal in humans: a double-blinded, randomized, placebo-controlled crossover study

References

• Committee on Advancing Pain Research C, Education BoHSPIoM. A call for cultural transformation of attitudes toward pain and its prevention and management. J Pain Palliat Care Pharmacother 2011;25: 365–369.
   PubMedGoogle Scholar
• Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007;297:249–251.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Helm S, 2nd, Fellows B, Janata JW, Pampati V, Grider JS, et al. Opioid epidemic in the United States. Pain Physician 2012; 15:ES9–E38.
   Google Scholar
• Kobinger W, Walland A. Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl. Eur J Pharmacol 1967;2:155–162.
   PubMed Web of Science ®Google Scholar
• Chu LF, Liang DY, Li X, Sahbaie P, D’Arcy N, Liao G, et al. From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics 2009;19:193–205.
   PubMed Web of Science ®Google Scholar
• Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 1990;36:97–104.
   PubMed Web of Science ®Google Scholar
• Gulati A, Bhargava HN. Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats. Eur J Pharmacol 1989;167:185–192.
   PubMed Web of Science ®Google Scholar
• Tao R, Ma Z, Auerbach SB. Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine. J Pharmacol Exp Ther 1998;286:481–488.
   PubMed Web of Science ®Google Scholar
• Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci 1998;18:10269–10276.
   PubMed Web of Science ®Google Scholar
• Tao R, Auerbach SB. Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain. Neuroscience 1995;68:553–561.
   PubMed Web of Science ®Google Scholar
• Pinelli A, Trivulzio S, Tomasoni L. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats. Eur J Pharmacol 1997;340:111–119.
   PubMed Web of Science ®Google Scholar
• Smith HS, Cox LR, Smith EJ. 5-HT3 receptor antagonists for the treatment of nausea/vomiting. Ann Palliat Med 2012;1:115–120.
   PubMedGoogle Scholar
• Compton P, Miotto K, Elashoff D. Precipitated opioid withdrawal across acute physical dependence induction methods. Pharmacol Biochem Behav 2004;77:263–268.
   PubMed Web of Science ®Google Scholar
• Grunberg SM, Koeller JM. Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis. Expert Opin Pharmacother 2003;4:2297–2303.
   PubMed Web of Science ®Google Scholar
• Mustian KM, Devine K, Ryan JL, Janelsins MC, Sprod LK, Peppone LJ, et al. Treatment of Nausea and Vomiting During Chemotherapy. US Oncol Hematol 2011;7:91–97.
   PubMedGoogle Scholar
• Smith HS, Laufer A. Opioid induced nausea and vomiting. Eur J Pharmacol 2014;722:67–78.
   PubMed Web of Science ®Google Scholar
• Mazurkiewicz-Kwilecki IM, Bielkiewicz B. The effects of chronic morphine treatment on histamine concentration and histidine decarboxylase activity in rat brain. Prog Neuropsychopharmacol 1978;2:93–99.
   PubMedGoogle Scholar
• Wong CL, Roberts MB. The possible role of brain histamine and H1 and H2 receptors in the development of morphine tolerance and physical dependence in mice. Agents Actions 1975;5:476–483.
   PubMedGoogle Scholar
• Wong CL, Roberts MB. The effects of L-histidine and of specific histamine receptor agonists, on the expression of morphine tolerance and physical dependence in mice. Agents Actions 1976;6:569–576.
   PubMedGoogle Scholar
• Hauser L, Anupindi, R., Moore, W. Hydroxyzine for the treatment of acute opioid withdrawal: a 20-year clinical experience. Resident Staff Physician 2006;52:24.
   Google Scholar
• Hoehe M. Influence of the menstrual cycle on neuroendocrine and behavioral responses to an opiate agonist in humans: preliminary results. Psychoneuroendocrinology 1988;13:339–344.
   PubMed Web of Science ®Google Scholar
• Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13:293–308.
   PubMed Web of Science ®Google Scholar
• Alsaadi SM, McAuley JH, Hush JM, Lo S, Lin CW, Williams CM, et al. Poor sleep quality is strongly associated with subsequent pain intensity in patients with acute low back pain. Arthritis Rheumatol 2014;66:1388–1394.
   PubMed Web of Science ®Google Scholar
• Schuh-Hofer S, Wodarski R, Pfau DB, Caspani O, Magerl W, Kennedy JD, et al. One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain 2013;154:1613–1621.
   PubMed Web of Science ®Google Scholar
• De Leon A. Palonosetron (Aloxi): a second-generation 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting. Proc (Bayl Univ Med Cent) 2006;19:413–416.
   PubMedGoogle Scholar
• Boon JH, Hopkins D. Hydroxyzine premedication–does it provide better anxiolysis than a placebo? S Afr Med J 1996;86:661–664.
   PubMed Web of Science ®Google Scholar
• Roychoudhury M, Kulkarni SK. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist. Methods Find Exp Clin Pharmacol 1996;18:677–683.
   PubMedGoogle Scholar
• Cui R, Suemaru K, Li B, Kohnomi S, Araki H. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors. Eur J Pharmacol 2009;609:74–77.
   PubMed Web of Science ®Google Scholar
• Araki H, Kawakami KY, Jin C, Suemaru K, Kitamura Y, Nagata M, et al. Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats. Psychopharmacology (Berl) 2004;171:398–404.
   PubMed Web of Science ®Google Scholar
• Motoshima S, Suemaru K, Kawasaki Y, Jin C, Kawasaki H, Gomita Y, et al. Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. Eur J Pharmacol 2005;519:91–95.
   PubMed Web of Science ®Google Scholar
• Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991;254:432–437.
   PubMed Web of Science ®Google Scholar
• Albertson TE, Chenoweth J, Ford J, Owen K, Sutter ME. Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes? J Med Toxicol 2014;10:369–381.
   PubMedGoogle Scholar
• Walsh SL, Strain EC, Bigelow GE. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans. Addiction 2003;98:427–439.
   PubMed Web of Science ®Google Scholar